Celltrion
068270.KS
#853
Rank
โ‚น2.444 T
Marketcap
โ‚น11,174
Share price
0.05%
Change (1 day)
7.50%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น165.10

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น169.61. In 2023 the company made an earnings per share (EPS) of โ‚น247.87 a decrease over its 2022 EPS that were of โ‚น253.14.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น165.10
2023โ‚น247.87-2.08%
2022โ‚น253.14-11.72%
2021โ‚น286.742.03%
2020โ‚น281.0382.8%
2019โ‚น153.7318.31%
2018โ‚น129.94-36.33%
2017โ‚น204.10161.25%
2016โ‚น78.122.86%
2015โ‚น75.9517.84%
2014โ‚น64.455.87%
2013โ‚น60.88-70.85%
2012โ‚น208.84134.09%
2011โ‚น89.2143.59%
2010โ‚น62.1374.49%
2009โ‚น35.61317.8%
2008โ‚น8.52-71.7%
2007โ‚น30.12